Culwell Kelly 4
4 · Evofem Biosciences, Inc. · Filed May 1, 2020
Insider Transaction Report
Form 4
Culwell Kelly
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-04-30$4.66/sh−1,000$4,660→ 195,226 total - Sale
Common Stock
2020-05-01$4.75/sh−1,000$4,750→ 194,226 total
Footnotes (1)
- [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.